This also stands in the way of another requirement one would otherwise make, ie, that the putative mechanism should be evident in offspring before the onset of significant atherosclerosis. Verification in humans will obviously be most important. In the past, the limited availability of cholesterol data during pregnancy has hindered retrospective investigation in offspring of mothers with perinatal hypercholesterolemia in most counties.9,10 Fortunately, recent data from the Framingham Study have shown a markedly increased cardiovascular risk in offspring of mothers who were hypercholesterolemic both sometime before and after pregnancy, and thus presumably also during pregnancy.2 This opens new opportunities to determine the atherogenic effects and mechanisms of maternal hypercholesterolemia using large multigenerational databases.
DisclosuresNone.
References